New funding led by Goldcrest Capital and Godfrey Capital to advance lead candidate JUN_01 for type 2 diabetes and obesity to first-in-human studiesJUN_01 would be the first ever candidate to reprogram ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback